Lessene, AU
Guillaume Lessene, Coburg AU
Patent application number | Description | Published |
---|---|---|
20130261119 | Novel Anti-Cancer Agents - The present invention provides a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or pro-drug thereof. Further provided is a method of treatment of cancer in a subject comprising administering to said subject an effective amount of a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or prodrug thereof. Further provided is the use of a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or prodrug thereof in the preparation of a medicament for the treatment of cancer. In addition, the present invention also provides a pharmaceutical composition comprising a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or prodrug thereof. | 10-03-2013 |
20150045365 | Novel Anti-Cancer Agents - The present invention provides a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or prodrug thereof. Further provided is a method of treatment of cancer in a subject comprising administering to said subject an effective amount of a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or prodrug thereof. Further provided is the use of a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or prodrug thereof in the preparation of a medicament for the treatment of cancer. In addition, the present invention also provides a pharmaceutical composition comprising a compound of Formula (I), or a pharmaceutical acceptable derivative, salt or prodrug thereof. | 02-12-2015 |
Guillaume Laurent Lessene, Victoria AU
Patent application number | Description | Published |
---|---|---|
20100056517 | ARYLSULFONAMIDE COMPOUNDS - The invention relates generally to small molecules that mimic the biological activity of certain peptides and proteins, to compositions containing them and to their use. In particular, the invention relates to compounds of the general formula (I) that mimic the biological activity of BH3-only proteins and are capable of binding to and neutralizing pro-survival Bcl-2 proteins: | 03-04-2010 |
20100197711 | BENZOTHIAZOLE COMPOUNDS - The present invention relates to benzothiazole compounds that mimic the activity of BH3 only proteins and are capable of binding to and neutralizing pro survival Bcl 2 proteins. The invention also relates to the use of such compounds in the regulation of cell death or cell survival and the treatment and/or prophylaxis of diseases or conditions associated with the deregulation of cell death or cell survival. | 08-05-2010 |
20110098305 | ARYLSULFONAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE - Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member. | 04-28-2011 |
Guillaume Laurent Lessene, Coburg AU
Patent application number | Description | Published |
---|---|---|
20100190782 | COMPOUNDS AND METHODS OF USE - In one aspect, the present invention provides for a compound of Formula I | 07-29-2010 |
20100210622 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE - In one aspect, the present invention provides for a compound of Formula I | 08-19-2010 |
20120184541 | COMPOUNDS AND METHODS OF USE - In one aspect, the present invention provides for a compound of Formula I | 07-19-2012 |
Guillaume Laurent Lessene, Parkville AU
Patent application number | Description | Published |
---|---|---|
20130184274 | Protein Kinase Inhibitors and Methods of Treatment - The present invention relates to chemical compounds of formula (I) and methods for their use and preparation. In particular, the invention relates to substituted pyrazolo[3,4-d]pyrimidine based compounds which can be used in treating proliferative disorders, use of these compounds in methods of therapy and the manufacture of medicaments as well as compositions containing these compounds. | 07-18-2013 |
Guillaume Laurent Lessene, Bundoora AU
Patent application number | Description | Published |
---|---|---|
20140005190 | COMPOUNDS AND METHODS OF USE | 01-02-2014 |
20140066621 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 03-06-2014 |
Romina Lessene, Bundoora AU
Patent application number | Description | Published |
---|---|---|
20130017194 | FAK INHIBITORS - A compound of the formula (I): | 01-17-2013 |
20130022594 | SELECTIVE FAK INHIBITORS - A compound of the formula (I): | 01-24-2013 |
20130324532 | FAK INHIBITORS - A compound of the formula (I): | 12-05-2013 |
20130324546 | SELECTIVE FAK INHIBITORS - A compound of the formula (I): | 12-05-2013 |
20140073620 | VEGFR3 INHIBITORS - This invention relates to a compound of the formula (I): | 03-13-2014 |
20140080798 | VEGFR3 INHIBITORS - This invention relates to compounds of the formula (I): | 03-20-2014 |